Nasdaq

Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data

Authorized for use in the U.S. in January 2021, Ortho's VITROS® SARS-CoV-2 Antigen Test offers reliable detection of SARS-CoV-2 in patients suspected of COVID-19 by their healthcare provider within ...
WBAL-TV

Coronavirus testing volume drops significantly in Maryland

EARLY ON IN THE PANDEMIC THE STATE’S VEHICLE EMISSION STATIONS. WHERE USED IS CORONAVIRUS TESTING SITE PART OF A STRATEGY TO RAMP UP TESTING TO TRY TO CONTAIN THE VIRUS HAS SPREAD. BUT THE EMISSION ...
Nasdaq

XiFin Launches New Lab Volume Index (LVI): Delivers Deeper Insights in Post-Pandemic Diagnostic Testing

New Lab Volume Index, Highlighting More Trends and Expanded Functionality, Shows Testing Capacity Being Absorbed by Doubling of Demand for Women’s Health, Led by Prenatal Testing New Lab Volume Index, ...
The Trentonian

Ortho’s VITROS(R) SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data

RARITAN, N.J., March 23, 2021 /PRNewswire/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it received authorization ...